x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Medical Industry Feature

Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.

science & medicine medicine

All Episodes

00:00:00

The ASCVD Journey With Lp(a): An ApoB-Family Lipoprotein

Medical Industry Feature ·

2023/06/22

Elevated lipoprotein(a), or Lp(a), is the most common inherited dyslipidemia that can drive the atherosclerotic process. So at what age does Lp(a) impact a patient’s life? To find out more, tune into this episode sponsored by Novartis. Sponsored by Novartis Pharmaceuticals Corporation. 6/23 278623

en

00:00:00

Letters from the Heart: People Should Know About Lp(a)

Medical Industry Feature ·

2023/06/22

It’s estimated that 20 percent of the world’s population has elevated Lp(a) greater than 50 milligrams per deciliter. Lp(a) is an independent, genetic, and causal risk factor for atherosclerotic cardiovascular diseases. For more insights, tune into this episode sponsored by Novartis. Sponsored by Novartis Pharmaceuticals Corporation. 6/23 278623

en

00:00:00

Understanding Lp(a): Clinical Implications of an...

Medical Industry Feature ·

2023/06/22

Guest: Santica Marcovina, PhD, ScD Lipoprotein(a), or Lp(a), is a unique apoB family lipoprotein that contains apo(a), which is a peculiar carbohydrate-rich protein covalently bound to an apoB lipoprotein. So are elevated Lp(a) levels a risk factor for atherosclerotic cardiovascular disease? Dive into this episode, sponsored by Novartis, to find out. Sponsored by Novartis Pharmaceuticals Corporation. 6/23 278623

en

00:00:00

Letters from the Heart: People Should Know About Lp(a)

Medical Industry Feature ·

2023/06/22

It’s estimated that 20 percent of the world’s population has elevated Lp(a) greater than 50 milligrams per deciliter. Lp(a) is an independent, genetic, and causal risk factor for atherosclerotic cardiovascular diseases. For more insights, tune into this episode sponsored by Novartis. Sponsored by Novartis Pharmaceuticals Corporation. 6/23 278623

en

00:00:00

The ASCVD Journey With Lp(a): An ApoB-Family Lipoprotein

Medical Industry Feature ·

2023/06/22

Elevated lipoprotein(a), or Lp(a), is the most common inherited dyslipidemia that can drive the atherosclerotic process. So at what age does Lp(a) impact a patient’s life? To find out more, tune into this episode sponsored by Novartis. Sponsored by Novartis Pharmaceuticals Corporation. 6/23 278623

en

00:00:00

Inherited Retinal Diseases, Genetic Testing, and What...

Medical Industry Feature ·

2023/06/21

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Mark Pennesi, MD, PhD Approximately 165,700 people in the United States are affected by inherited retinal diseases (IRDs) and treatment options for these conditions are limited. So what role does genetic testing play in the patient journey of people living with IRDs? Join Dr. Charles Turck as he dives into this topic with Dr. Mark Pennesi, Professor of Ophthalmology and an IRD specialist affiliated with the Casey Eye Institute at the

en

00:00:00

Future Imaging Modalities in Spondyloarthritis

Medical Industry Feature ·

2023/05/18

Host: Ethan Craig, MD, MHS Guest: Walter Maksymowych, MB ChB, FRCP(C), FACP Appealing treatment options for patients with SpA might be right around the corner. So why do we need further imaging modalities and what do they have to offer? To give us a peek into the future, Dr. Ethan Craig is joined by Dr. Maksymowych, Professor of Medicine at the University of Alberta and Chief Medical Officer of CARE Arthritis. Dr. Craig and Dr. Bakewell are Novartis Consultants. 269162 03/23

en

00:00:00

The Role of Imaging in Determining Treatment...

Medical Industry Feature ·

2023/05/04

Host: Ethan Craig, MD, MHS Guest: Catherine J. Bakewell, MD Disease activity in patients with spondyloarthritis (SpA) may be challenging to assess. So when should ultrasound and MRI be used to support clinical assessment? To provide us with more insights into this topic, Dr. Ethan Craig is joined by Dr. Catherine Bakewell, Rheumatologist at Intermountain Healthcare in Salt Lake City, Utah. Dr. Craig and Dr. Bakewell are Novartis Consultants. 269162 03/23

en

00:00:00

A Changing Paradigm for Cancer Screening: Exploring...

Medical Industry Feature ·

2023/04/24

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Eric Klein, MD Cancer remains the second-leading cause of death in the U.S., creating an urgent need to detect cancer at earlier stages when outcomes are better. With the emergence of novel multi-cancer screening technologies, the potential public health impact may be substantial. Given these advances, is it time to rethink the way clinical trials are designed to assess the effectiveness of these screening technologies? Joining Dr

en

00:00:00

Using MRI to Differentiate Axial Spondyloarthritis...

Medical Industry Feature ·

2023/04/20

Host: Ethan Craig, MD, MHS Guest: Walter Maksymowych, MB ChB, FRCP(C), FACP Over the last 20 year or so, magnetic resonance imaging (MRI) has changed how we evaluate axial spondyloarthritis (axSpA). But with a concerning rate of false-positive MRIs in recent data, it’s time to review where the field stands now, and update what the role of MRI seems to be in the diagnosis of spondyloarthritis (SpA). Join Dr. Ethan Craig in this discussion with an expert in SpA imaging, Dr

en

00:00:00

The Value of CINtec® PLUS Cytology Test in Cervical...

Medical Industry Feature ·

2023/04/14

Host: Jennifer Caudle, DO Guest: Tamera A. Paczos, MD, FACOG, FACP The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A. Paczos, Vice President, Associate Chief Medical Officer with BioReference Laboratories. COBAS and CINTEC are trademarks of Roche.All

en

00:00:00

Differentiating Peripheral Spondyloarthritis from...

Medical Industry Feature ·

2023/04/06

Host: Ethan Craig, MD, MHS Guest: Catherine J. Bakewell, MD Diagnosing patients with peripheral spondyloarthritis (pSpA) can often be challenging, particularly when differentiating it from other causes of inflammatory and non-inflammatory arthritis. So what is the role of ultrasound when diagnosing pSpA in patients? Join Dr. Ethan Craig as he guides this discussion with Dr. Catherine Bakewell, Rheumatologist at Intermountain Healthcare in Salt Lake City, Utah. Dr. Craig and Dr

en

00:00:00

Understanding Biosimilars: What's Driving Adoption &...

Medical Industry Feature ·

2023/03/30

Host: Jennifer Caudle, DO Guest: Stefanie Cribb, PharmD Guest: Ryan Haumschild, PharmD Guest: Jennifer Rubin Guest: Ira Steinberg, MD There’s been a lot of focus recently on biosimilars and their potential role in evolving the healthcare system. We're digging in deeper to understand what makes biosimilars so exciting. Joining Dr. Jennifer Caudle to discuss the biosimilar approval process and the important commitment supporting healthcare providers and patients in their

en

00:00:00

Hybrid Model for Contraceptive Care in Private Practice

Medical Industry Feature ·

2023/03/28

Guest: Edmund Kim, MD The COVID-19 pandemic impacted the way contraceptive care was offered to patients, with many offices turning to telemedicine.1 Telemedicine can be used while still offering long-acting reversible contraception (LARC) options by implementing a hybrid model for care.2,3 This type of approach consists first of a telemedicine appointment to counsel patients on all appropriate contraceptive options and, if necessary, an in-person appointment to initiate any

en

00:00:00

Rethinking Diabetes Care: Key Data from Incorporating...

Medical Industry Feature ·

2023/03/20

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jamy Ard, MD Guest: Michelle I. Cardel, PhD, MS, RD Addressing obesity may be a key component of diabetes management, so integrating strategies to manage obesity may improve diabetes care. To better understand this, Dr. Jamy Ard and Dr. Michelle Cardel dive into the impact of evidence-based lifestyle interventions for people living with diabetes. WW Logo and Weight Watchers are the trademarks of WW International, Inc. and are used

en

00:00:00

Understanding the Role of TSLP in Severe Asthma

Medical Industry Feature ·

2023/03/13

Host: Matt Birnholz, MD Guest: Jonathan Corren, MD As recent research demonstrates the important role that TSLP plays in asthma inflammation, Dr Matt Birnholz is joined by Dr Jonathan Corren, an Associate Clinical Professor of Medicine and Pediatrics at David Geffen School of Medicine in Los Angeles. Together, they review how TSLP acts across the spectrum of asthma inflammation, the correlation of TSLP with clinical features of asthma, and more. ©2021 Amgen. All rights reserved

en

00:00:00

GlyNAC and Healthy Aging: A Review of New Clinical Data

Medical Industry Feature ·

2023/03/10

Guest: Rajagopal Sekhar, MD Clinicians are still working to understand the mechanisms behind age-related declines and what interventions might help promote healthy aging. Could supplementation with the nutritional compounds glycine and n-acetylcysteine (GlyNAC) play a role by improving intracellular antioxidant levels? Dr. Rajagopal Sekhar shares the latest clinical data on GlyNAC supplementation in older adults.

en

00:00:00

Hereditary Angioedema: A Perspective on Prophylactic...

Medical Industry Feature ·

2023/01/27

Guest: Dr. Timothy Craig Hereditary angioedema (HAE) is a rare genetic disease that can cause recurrent, unpredictable, and potentially life-threatening attacks of swelling in the body.2 The unpredictability of these attacks is a significant burden on patients.3 Fortunately, preventive treatments like TAKHZYRO® (lanadelumab-flyo) can help reduce the frequency and severity of HAE attacks.1 Here to share key information and data on this treatment option is Dr. Timothy Craig, Professor of

en

00:00:00

Effective Prevention for Hereditary Angioedema Attacks

Medical Industry Feature ·

2023/01/27

Host: Jennifer Caudle, DO Guest: William Lumry, MD Hereditary angioedema (HAE) is a rare, genetic disease that can cause recurrent, unpredictable, and potentially life-threatening attacks of swelling in the body.1 These swelling attacks can be both painful and debilitating, which is why prevention is so important.1 So what are the treatment options available that can help prevent HAE attacks? Joining Dr. Jennifer Caudle to discuss the importance of long-term prevention for HAE and

en

00:00:00

Exploring an Evolving Treatment Paradigm for...

Medical Industry Feature ·

2022/11/08

Guest: Marc Riedl, MD, MS Prior to 2008, there were limited approved treatment options for hereditary angioedema (HAE) available in the United States, but today, there are several medications approved by the U.S. Food and Drug Administration for preventing and treating HAE attacks.1 In light of the number of therapies that have been approved in recent years and continued clinical advancements in HAE research, what do we need to consider when discussing these treatment options with our

en

100 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事